{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:28:40Z","timestamp":1792898920292,"version":"4.5.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases"],"published-print":{"date-parts":[[2017,7,3]]},"DOI":"10.1080\/23744235.2017.1296968","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T06:57:46Z","timestamp":1488869866000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":33,"title":["Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic"],"prefix":"10.1080","volume":"49","author":[{"given":"Ranjeet Prasad","family":"Dash","sequence":"first","affiliation":[{"name":"Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, AL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jayachandra","family":"Babu","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, AL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuggehally R.","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Zydus Research Centre, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03395-15"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2016.03.012"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1187599"},{"key":"CIT0004","unstructured":"European Medicines AgencyXydalba 500\u2009mg powder for concentrate for solution for infusion: summary of product chracteristics [Internet]. [cited 2016 Nov 16]. 2015. Available from: http:\/\/www.ema.europa.eu."},{"key":"CIT0005","unstructured":"Durata Therapeutics US Ltd. Dalvance (dalbavancin) for injection, for intravenous use: US prescribing information [Internet]. [cited 2016 Nov 16]. 2014. Available from: http:\/\/www.dalvance.com\/."},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.11.007"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.2165\/11534440-000000000-00000"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.1.80"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070255"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2174\/0929867013371716"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.781"},{"key":"CIT0012","first-page":"313","volume":"52","author":"Ciabatti R","year":"1997","journal-title":"Farmaco"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00116-16"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.04.009"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S86330"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0430-x"},{"key":"CIT0017","unstructured":"Center for Drug Evaluation and Research Application Number: 021883Orig1s000 [cited 2016 Nov 16]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/021883Orig1s000Approv.pdf."},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki006"},{"key":"CIT0019","first-page":"229","volume":"3","author":"Steiert M","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.05.019"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00020-07"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.940-945.2004"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm263"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04550-14"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005280378"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki008"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-015-0340-4"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000646"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008321273"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008330162"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.12388"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2015.08.006"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03147-14"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.01.018"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki004"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039030-00001"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.1.148-152.2005"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.2.788-790.2006"},{"key":"CIT0039","unstructured":"Highlights of Prescribing Information. Dalvance (dalbavancin) for injection, for intravenous use Initial U.S. Approval: 2014 [cited 2016 Nov 16]. Available from: http:\/\/www.allergan.com\/assets\/pdf\/dalvance_pi."},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000401"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2756-z"},{"key":"CIT0042","first-page":"291","volume":"9","author":"Stogniew M","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/66.2.185"}],"container-title":["Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/23744235.2017.1296968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T13:30:25Z","timestamp":1500643825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/23744235.2017.1296968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,3,6]]},"published-print":{"date-parts":[[2017,7,3]]}},"alternative-id":["10.1080\/23744235.2017.1296968"],"URL":"https:\/\/doi.org\/10.1080\/23744235.2017.1296968","relation":{},"ISSN":["2374-4235","2374-4243"],"issn-type":[{"value":"2374-4235","type":"print"},{"value":"2374-4243","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=infd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=infd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}